Surgical & Medical Instruments & Apparatus·AUSTIN, TX
Financials
20 shown
Type
Period
Ended
Filed
10-Q
Q3 2025
9/30/25
10/30/25
→
10-Q
Q2 2025
6/30/25
8/14/25
→
10-Q
Q1 2025
3/31/25
5/30/25
→
10-K/A
FY 2024
12/31/24
4/30/25
→
10-K
FY 2024
12/31/24
3/31/25
→
10-Q
Q3 2024
9/30/24
11/14/24
→
↓
Earnings Releases (8-K)
22 shown
Filed
Period
10/30/25
Q3 FY2025
→
8/14/25
Q3 FY2025
→
5/30/25
Q2 FY2025
→
3/27/25
Q1 FY2025
→
11/14/24
Q4 FY2024
→
8/14/24
Q3 FY2024
→
↓
News (8-K)
58 shown
Filed
Type
Description
2/13/26
Exec Change
Departure or Appointment of Directors or Certain Officers
→
1/22/26
Other
Other Events
→
1/16/26
Agreement
Entry into a Material Definitive Agreement
→
11/17/25
Reg FD
Regulation FD Disclosure
→
10/21/25
Agreement
Entry into a Material Definitive Agreement
→
8/26/25
Other
Other Events
→
↓
Prospectuses & Registrations
40 shown
Filed
Form
Description
1/14/26
424B4
424B4
→
1/13/26
S-1MEF
S-1MEF
→
1/9/26
S-1
S-1
→
8/22/25
S-8
S-8
→
8/15/25
424B3
424B3
→
8/12/25
S-1
S-1
→
↓
Filing History(1004 filings)
TypeDateAccessionPeriodSize
RW
Mar 6, 2026
0001193125-26-096495RW
—
7.4 KB
4
Feb 27, 2026
0001193125-26-0826074
Feb 25, 2026
7.8 KB
4
Feb 27, 2026
0001193125-26-0825844
Feb 25, 2026
7.8 KB
8-K
Feb 13, 2026
0001193125-26-0513798-K
Feb 9, 2026
244.4 KB
SCHEDULE 13G
Jan 22, 2026
0001649553-26-000002
—
15.1 KB
8-K
Jan 22, 2026
0001193125-26-0186758-K
Jan 22, 2026
12.0 MB
8-K
Jan 16, 2026
0001193125-26-0153468-K
Jan 13, 2026
423.7 KB
424B4
Jan 14, 2026
0001193125-26-012905424B4
—
1.9 MB
EFFECT
Jan 13, 2026
9999999995-26-000164
—
1.9 KB
S-1MEF
Jan 13, 2026
0001193125-26-012091S-1MEF
—
310.3 KB
S-1
Jan 9, 2026
0001193125-26-008922S-1
—
13.3 MB
4
Jan 2, 2026
0001193125-26-0009674
Jan 1, 2026
7.0 KB
4
Jan 2, 2026
0001193125-26-0009664
Jan 1, 2026
7.0 KB
DRS
Nov 25, 2025
0001193125-25-294028
—
387.5 KB
8-K
Nov 17, 2025
0001193125-25-2839358-K
Nov 17, 2025
151.3 KB
4
Nov 5, 2025
0001193125-25-2658664
Nov 4, 2025
5.1 KB
10-Q
Oct 30, 2025
0001193125-25-25859610-Q
Sep 30, 2025
10.0 MB
8-K
Oct 30, 2025
0001193125-25-2585688-K
Oct 30, 2025
613.5 KB
8-K
Oct 21, 2025
0001193125-25-2442758-K
Oct 16, 2025
1.2 MB
4
Oct 3, 2025
0001193125-25-2302964
Oct 1, 2025
7.0 KB
4/A
Oct 3, 2025
0001193125-25-2302924/A
Aug 13, 2025
7.8 KB
4
Oct 3, 2025
0001193125-25-2302914
Oct 1, 2025
7.0 KB
4/A
Oct 3, 2025
0001193125-25-2302884/A
Aug 13, 2025
7.8 KB
8-K
Aug 26, 2025
0001193125-25-1880758-K
Aug 26, 2025
139.7 KB
4
Aug 25, 2025
0000950170-25-1110924
Aug 22, 2025
4.5 KB
25 filings shown
Proxies
34 shown
Filed
Form
Description
8/1/25
DEFA14A
DEFA14A
→
7/21/25
DEF 14A
DEF 14A
→
7/11/25
PRE 14A
PRE 14A
→
5/1/25
DEFA14A
DEFA14A
→
4/10/25
DEF 14A
DEF 14A
→
3/14/25
PRE 14A
PRE 14A
→
↓
Ownership
40 shown
Filed
Form
Description
2/27/26
4
4
→
2/27/26
4
4
→
1/2/26
4
4
→
1/2/26
4
4
→
11/5/25
4
4
→
10/3/25
4
4
→
↓
Other Filings
40 shown
Filed
Form
Description
3/6/26
RW
RW
→
1/22/26
SCHEDULE 13G
SCHEDULE 13G
→
1/13/26
EFFECT
EFFECT
→
11/25/25
DRS
DRS
→
8/14/25
EFFECT
EFFECT
→
8/14/25
SCHEDULE 13G/A
SCHEDULE 13G/A
→
↓
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system (CNS) cancers.